Jeff Yass’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,032
Closed -$277K 13466
2024
Q2
$217K Sell
8,032
-3,317
-29% -$65.4K ﹤0.01% 10177
2024
Q1
$245K Buy
+11,349
New +$248K ﹤0.01% 10158

Jeff Yass's LBPH Position: Q3 2024 in Review

Jeff Yass sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q3 2024, closing a stake of 8,032 shares — an estimated $277K sold.

Jeff Yass first reported a position in LBPH in Q1 2024 and held it in 2 quarters. The position peaked at $245K in Q1 2024. 125 funds tracked by Wall St. Rank hold LBPH as of Q3 2024.

  • Jeff Yass reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Jeff Yass sold 8,032 Longboard Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $277K.
  • Jeff Yass first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Jeff Yass's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $245K in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.